Consideration for the acquisition, in sales royalties in connection with future net sales related.

No definition available.

Name:	notv_SalesRoyaltiesInConnectionWithFutureNetSales
Namespace Prefix:	notv_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Number of shares of equity interests issued or issuable to acquire entity.

+ References

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Gross amount of debt extinguished.

+ References

No definition available.

+ Details

Name:	us-gaap_ExtinguishmentOfDebtAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585

+ Details

Name:	us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsequentEventLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=notv_BioRelianceCorporationAndBSIGaithersburgLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=notv_LaboratoryInstrumentationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=notv_GatewayPharmacologyLaboratoriesLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DebtInstrumentAxis=notv_PaycheckProtectionProgramLoanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

SUBSEQUENT EVENTS (Details) - USD ($) $ in Thousands					9 Months Ended
SUBSEQUENT EVENTS (Details) - USD ($) $ in Thousands	Aug. 02, 2021	Jul. 16, 2021	Jul. 15, 2021	Jul. 09, 2021	Jun. 30, 2021	Jun. 30, 2020
SUBSEQUENT EVENTS
Consideration in cash					$ 40,698	$ 4,000
Subsequent events \| BioReliance and BASi Gaithersburg
SUBSEQUENT EVENTS
Consideration for acquisition in sales royalties in connection with future net sales related (as a percent)				10.00%
Subsequent events \| Laboratory Instrumentation
SUBSEQUENT EVENTS
Consideration in cash			$ 1,300
Subsequent events \| Gateway Pharmacology Laboratories LLC
SUBSEQUENT EVENTS
Consideration in cash	$ 1,400
Shares issued	45,323
Common shares value	$ 1,250
Subsequent events \| PPP Loan
SUBSEQUENT EVENTS
Forgiveness of debt		$ 4,851